C
Amphastar Pharmaceuticals, Inc. AMPH
$29.79 -$0.715-2.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 134.71M 141.63M 159.52M 157.72M 166.52M
Total Depreciation and Amortization 60.54M 58.45M 57.21M 56.33M 55.47M
Total Amortization of Deferred Charges 3.07M 4.67M 6.03M 8.22M 12.71M
Total Other Non-Cash Items 12.49M 12.43M 5.18M 18.66M 9.02M
Change in Net Operating Assets -51.16M -24.00M -14.55M -32.70M -31.12M
Cash from Operations 159.66M 193.17M 213.39M 208.23M 212.60M
Capital Expenditure -47.47M -42.95M -41.04M -38.07M -34.47M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 0.00 -129.00M -129.00M -129.00M -134.58M
Divestitures -- -- -- -- --
Other Investing Activities -12.94M 42.26M 45.11M -25.23M -19.82M
Cash from Investing -60.41M -129.69M -124.93M -192.30M -188.87M
Total Debt Issued 20.15M 15.99M 18.43M 13.57M 349.06M
Total Debt Repaid -231.00K -8.20M -8.26M -58.30M -258.33M
Issuance of Common Stock 494.00K -- -- 3.56M 5.69M
Repurchase of Common Stock -120.53M -88.68M -90.31M -51.69M -70.00M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -1.24M -986.00K -816.00K -1.33M -11.18M
Cash from Financing -101.36M -81.88M -80.95M -94.19M 15.24M
Foreign Exchange rate Adjustments 186.00K 25.00K -190.00K -417.00K -392.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -1.93M -18.37M 7.31M -78.69M 38.57M